亚特兰大 - 专注于非阿片类止痛治疗的生物制药公司Dogwood Therapeutics, Inc. (NASDAQ: DWTX )今日宣布向特定机构投资者进行注册定向增发。公司将以每股$8.26的价格发行578,950股普通股，预计在扣除费用和支出前的总收益约为$4.8百万。该发行预计将于2025年3月14日完成交割，但需满足标准交割条件。根据 InvestingPro ...

Proceeds from today’s financing, when added to existing cash, fund operations through Q1 2026 The Company is planning to ...

Inc. agrees to conversion of debt into equity, removing all existing debt from Dogwood’s balance sheetATLANTA, March 12, 2025 ...

Therapeutics entered into a securities purchase agreement with certain institutional investors to purchase 578,950 shares of ...

Therapeutics announces that its largest shareholder, CK Life Sciences has agreed, through its wholly-owned subsidiary, Conjoint, ...

格隆汇3月12日丨长江生命科技(00775.HK)公告，根据贷款协议，2024年贷款中16.5百万美元已获买方Dogwood Therapeutics, Inc.于2024年10月7日提取，而2025年贷款中3百万美元已获买方于2025年2月18日提取，而截至2025年3月12日的应计利息为426,891美元。

ATLANTA, March 12, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a development-stage biopharmaceutical ...

QUINCY — Registration is now open for the 2025 Dogwood Parade, sent to stroll down Maine Street on May 3. This year's theme, ...

The Dogwood Arts Festival is an annual celebration of art and culture in East Tennessee. The festival is a well-loved ...